Robert Monroe

Robert Monroe

Opinion author

Robert Monroe, MD, PhD, is chief scientific officer of Oncology at Danaher Diagnostics and chief medical officer at Leica Biosystems.

Only with the adoption of digital imaging and AI-powered analysis will next-generation precision oncology therapies reach their full potential and ensure no eligible patient is overlooked.